EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis

Bahareh Zarin, Reza Nedaeinia, Ismail Laher, Mostafa Manian, Shaghayegh Haghjooy Javanmard

Tumor Biology · 2023

DOI: 10.3233/tub-220020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumor Biology, 2023. Verfasst von Bahareh Zarin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hypoxia is the most common signature of the tumor microenvironment that drives tumorigenesis through the complex crosstalk of a family of transcription factors called hypoxia-inducible factors (HIFs), with other intercellular signaling networks. Hypoxia increases transforming growth factor-beta (TGF-β) expression. TGF-β and HIF-1α play critical roles in several malignancies and their interactions in melanoma progression remain unknown. Therefore, the aim of this study was to assess the impact of inhibiting activin receptor-like kinase-5 (ALK5), a TGF-β receptor, on the response to HIF-1α activation or inhibition in melanoma tumor progression. MATERIALS AND METHODS: Tumors were induced in C57BL/6J mice by subcutaneous inoculation with B16F10 melanoma cells. Mice were divided into HIF-1α inhibitor, ALK5 inhibitor (1 mg/kg) and HIF-1α inhibitor (100 mg/kg), ALK5 inhibitor, HIF-1α activator (1000 mg/kg), HIF-1α activator and ALK5 inhibitor, and control groups to receive inhibitors and activators through intraperitoneal injection. The expression of E-cadherin was evaluated by RT-qPCR. Vessel density and platelet-derived growth factor receptor beta (PDGFR)-β + cells around the vessels were investigated using immunohistochemistry. RESULTS: The groups receiving HIF-1α inhibitor and activator showed lower and higher tumor growth compared to the control group, respectively. E-cadherin expression decreased in all groups compared to the control group, illustrating the dual function of E-cadherin in the tumor microenvironment. Vascular density was reduced in the groups given HIF-1α inhibitor, ALK5 inhibitor, and ALK5 and HIF-1α inhibitor simultaneously. The percentage of PDGFR-β + cells was reduced in the presence of HIF-1α inhibitor, ALK5 inhibitor, HIF-1α and ALK5 inhibitors, and upon simultaneous treatment with HIF-1α activator and ALK5 inhibitor. CONCLUSION: Despite increased expression and interaction between TGF-β and HIF-1α pathways in some cancers, in melanoma, inhibition of either pathway alone may have a stronger effect on tumor inhibition than simultaneous inhibition of both pathways. The synergistic effects may be context-dependent and should be further evaluated in different cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaHumansMiceAnimalsMice, Inbred C57BLTransforming Growth Factor betaHypoxiaCadherinsHypoxia-Inducible Factor 1, alpha SubunitCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

ALK5AngiogenesisHIF-1αTGF-βmelanoma tumor

Substanzen

Transforming Growth Factor betaCadherinsHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada.
  • Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Zitieren

APA

Zarin, B., Nedaeinia, R., Laher, I., Manian, M., & Javanmard, S. H. (2023). The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis. Tumor Biology. https://doi.org/10.3233/tub-220020

Vancouver

Zarin B, Nedaeinia R, Laher I, Manian M, Javanmard SH. The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis. Tumor Biology. 2023. doi:10.3233/tub-220020

BibTeX
@article{Zarin2023,
  author = {Zarin, Bahareh and Nedaeinia, Reza and Laher, Ismail and Manian, Mostafa and Javanmard, Shaghayegh Haghjooy},
  title = {The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis},
  journal = {Tumor Biology},
  year = {2023},
  doi = {10.3233/tub-220020}
}
Kostenlos starten →